VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemesMarketEarningsCompareWatchlistInsider
BGLCBioNexus Gene Lab Corp.
$2.10$4M
Research
Overview
Valuation
ValuationTargetsPrice
Financials
RevenueEarningsP/ERatiosDividend
Ownership
Holders
Tools
Total ReturnDCA Calculator
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

Follow VCP Scanner on XFollow VCP Scanner on LinkedIn
© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
HomeStocksBGLCPrice History

BGLC logoBioNexus Gene Lab Corp. (BGLC) Stock Price History

Historical prices from 2021 to 2026

$2.10-0.32  (-13.43%)close Jun 24
Returns
1M
+1.2%
3M
-19.2%
YTD
-46.8%
1Y
-21.5%
3Y
-66.1%
5Y
-59.7%
ATH$322.90Jan 2021-99.4%
ATL$1.07Jun 2026pre-split
Avg Vol (50D)116K/ day
52-Week Range$1.07 — $15.60
LowCurrent: $2.10High

Loading 10-year price history...

BGLC Historical Performance

1 YearTotal Return
-21.5%
Price: -21.5%
3 YearsTotal Return
-96.1%
CAGR: -66.1%
Price: -96.1%
5 YearsTotal Return
-98.9%
CAGR: -59.7%
Price: -98.9%
YTD
-46.8%

BGLC Annual Returns

Year-by-year price performance · 2021–2026

Best-1.0%2025
Worst-95.6%2023
Up years0/6
2021-3.2%
2022-52.5%
2023-95.6%
2024-46.4%
2025-1.0%
2026-30.9%
2021 annual price return
-3.2%
2022 annual price return
-52.5%
2023 annual price return
-95.6%
2024 annual price return
-46.4%
2025 annual price return
-1.0%
2026 annual price return
-30.9%
LessMore
Alpha vs S&P 500
1Y-42.4%
3Y-84.6%
5Y-70.0%

Price returns only.

Download Historical Data

1,044 records • Includes OHLCV + Technical Indicators (MA50, MA200, RSI)

Free sign in required to download data

BGLC Stock Price Trajectory (2021–2026)

As of June 25, 2026, BioNexus Gene Lab Corp. (BGLC) trades at $2.10, representing a -21.5% return over the past year. The stock has delivered a -98.9% total return over five years (-59.7% CAGR), reflecting challenging market conditions.

The stock reached its all-time high of $322.90 on January 19, 2021. From this peak, BGLC has corrected -99.4%, currently trading 39% below its 200-day moving average, suggesting potential weakness.

When compared to Healthcare sector peers QDEL (-57.4% 1Y), CLOV (+83.5% 1Y), and RNAZ (-37.2% 1Y), BGLC has underperformed the peer group average. Compare BGLC vs QDEL →

BGLC Historical Price Data · from 2021

Rows 1–50 of 1,044
Date Open High Low Close Volume Change %
2026-06-242.182.182.102.1028K-13.43%
2026-06-232.352.472.302.4227K0.00%
2026-06-222.602.602.412.4214K-7.28%
2026-06-182.432.612.352.6192K+3.57%
2026-06-172.492.602.352.5216K-3.08%
2026-06-162.432.602.432.6016K+4.00%
2026-06-152.152.702.032.5024K+7.30%
2026-06-122.132.341.972.33134K+10.43%
2026-06-111.742.171.642.11111K+7.11%
2026-06-102.072.171.071.974.79M-9.43%
2026-06-092.162.202.152.177K-0.68%
2026-06-082.202.202.192.191K-0.45%
2026-06-052.182.202.142.205K-4.14%
2026-06-042.192.292.182.291K+0.66%
2026-06-032.142.302.142.283K+5.07%
2026-06-022.182.232.112.176K-3.13%
2026-06-012.222.402.192.2410K-3.45%
2026-05-292.402.402.082.32213K-1.28%
2026-05-282.362.402.232.3516K+5.86%
2026-05-272.052.422.052.2228K+7.25%
2026-05-262.022.192.002.0733K+2.73%
2026-05-222.012.022.002.022K-0.25%
2026-05-212.082.082.022.023K-3.35%
2026-05-202.032.092.032.092K-0.48%
2026-05-192.042.102.022.108K+0.48%
2026-05-181.982.101.982.0911K+3.51%
2026-05-151.992.081.982.023K+1.97%
2026-05-141.951.981.951.9813K+0.25%
2026-05-131.991.991.971.986K-1.99%
2026-05-122.022.032.002.022K-2.18%
2026-05-112.062.062.032.069K0.00%
2026-05-082.152.152.052.063K-0.96%
2026-05-072.012.142.012.082K+3.94%
2026-05-062.112.112.002.004K-1.91%
2026-05-052.142.142.042.042K0.00%
2026-05-042.092.092.042.042K-1.86%
2026-05-012.022.082.002.083K-1.01%
2026-04-302.102.102.102.10471+1.94%
2026-04-292.052.162.052.064K-0.48%
2026-04-282.082.132.072.078K-4.61%
2026-04-272.222.222.122.1710K-2.25%
2026-04-242.212.222.182.224K-0.45%
2026-04-232.192.232.192.23544+0.45%
2026-04-222.262.262.212.22345-1.77%
2026-04-212.302.302.222.262K-0.87%
2026-04-202.262.282.152.284K+3.63%
2026-04-172.202.202.202.201K+1.03%
2026-04-162.192.292.182.188K-0.11%
2026-04-152.312.312.162.182K+0.46%
2026-04-142.172.172.172.171K-3.98%
…
Consensus-Based Analysis Tools

Intrinsic Valuation

DCF models, multiple analysis, and analyst estimates.

Check Valuation

Historical Returns

10-year return with dividends reinvested.

Calculate

DCA Calculator

See how regular investing compounds over time.

Run Numbers

Peer Comparison

Compare growth, multiples, and margins vs sector.

Compare

BGLC — Frequently Asked Questions

Quick answers to the most common questions about buying BGLC stock.

How has BGLC stock performed recently?

BGLC declined -21.5% over the past year, below its 5-year annualized CAGR of -59.7%. The stock trades below its 200-day moving average, reflecting the downtrend.

What is BGLC's all-time high price?

BioNexus Gene Lab Corp. reached $322.90 on 2021-01-19. The 52-week high is $15.60. Current 1-year return of -21.5% places the stock further from historical peaks.

Where can I download BGLC historical price data?

This page provides BGLC daily OHLCV data with 50-day MA, 200-day MA, and RSI indicators. Data spans 2021-2026, downloadable in CSV format.

349 data points · sampled from 1,044